Skip to main content
. 2023 Dec 4;28:100636. doi: 10.1016/j.lana.2023.100636

Table 1.

Baseline covariates of new intakes at opioid treatment programs, by COVID-19 exposure (N = 821).

Pre-COVID (n = 386)
Post-COVID (n = 435)
No. (%)/Mean (SD) No. (%)/Mean (SD)
Age 39.6 (11.7) 38.8 (11.1)
Age group ≥ 40 165 (42.8) 171 (39.3)
Gender
 Male 236 (61.1) 256 (58.9)
 Female 150 (38.9) 179 (41.1)
Race
 White 272 (70.5) 336 (77.2)
 Black 50 (12.9) 35 (8.1)
 Asian 2 (0.5) 1 (0.2)
 Native Hawaiian, Pacific Islander 3 (0.8) 2 (0.5)
 American Indian Alaskan Native 10 (2.6) 12 (2.8)
 Other (including multi-race) 29 (7.5) 35 (8.0)
 Missing 20 (5.2) 14 (3.2)
Ethnicity
 Hispanic 35 (9.1) 48 (11.0)
 Non-Hispanic 273 (70.7) 312 (71.7)
 Missing 78 (20.2) 75 (17.2)
Health insurance
 None 59 (15.3) 59 (13.6)
 Grant Funded 36 (9.3) 33 (7.6)
 Medicaid 249 (64.5) 290 (66.7)
 Medicare 14 (3.6) 22 (5.1)
 Medicaid and Medicare 10 (2.6) 8 (1.8)
 Commercial insurance 10 (2.6) 17 (3.9)
 Other (including missing) 8 (2.1) 6 (1.4)
Marital status
 Never married 137 (35.5) 160 (36.8)
 Married 95 (24.6) 89 (20.5)
 Formerly married 64 (16.6) 77 (17.7)
 Single (Unknown marital status) 87 (22.5) 98 (22.5)
 Missing 3 (0.8) 11 (2.5)
Highest level of education attained
 <8 years 14 (3.6) 25 (5.7)
 Some high school 94 (24.4) 95 (21.8)
 High school graduate 141 (36.5) 176 (40.5)
 Some college 83 (21.5) 97 (22.3)
 College graduate 39 (10.1) 30 (6.9)
 Missing 15 (3.9) 12 (2.8)
Housing status
 Homeless 61 (15.8) 62 (14.2)
 Unstable 80 (20.7) 94 (21.6)
 Secure housing 224 (58.0) 256 (58.9)
 Other 12 (3.1) 17 (3.9)
 Missing 9 (2.3) 6 (1.4)
Employment status
 Full-time 72 (18.7) 83 (19.1)
 Part-time 39 (10.1) 35 (8.1)
 Retired 6 (1.6) 3 (0.7)
 Disabled 46 (11.9) 45 (10.3)
 Student 1 (0.3) 1 (0.2)
 Unemployed 139 (36.0) 162 (37.2)
 Out of label force 76 (19.7) 99 (22.8)
 Missing 7 (1.8) 7 (1.6)
Arrest within 30 days
 Yes 13 (3.4) 14 (3.2)
 No 223 (57.8) 245 (56.3)
 Missing 150 (38.9) 176 (40.5)
Criminal justice involvement
 Yes 265 (68.6) 297 (68.3)
 No 89 (23.1) 95 (21.8)
 Missing 32 (8.3) 43 (9.9)
HIV
 Yes 13 (3.4) 7 (1.6)
 No 193 (50.0) 222 (51.0)
 Missing 180 (46.6) 206 (47.4)
Hepatitis C
 Yes 145 (37.6) 155 (35.6)
 No 163 (42.3) 199 (45.8)
Onset age of opioid use 24.7 (9.9) 23.6 (8.7)
Onset age of opioid use group
 <18 114 (29.5) 135 (31.0)
 18–25 126 (32.6) 150 (34.5)
 ≥18 130 (33.9) 132 (30.3)
 Missing 16 (4.1) 18 (4.1)
Primary route for opioid use
 Oral 29 (7.5) 21 (4.8)
 Smoking 8 (2.1) 12 (2.8)
 Intranasal 119 (30.8) 127 (29.2)
 Injection 212 (54.9) 262 (60.2)
Drug use disordera
 Alcohol 33 (8.6) 38 (8.7)
 Opioid 384 (99.5) 432 (99.3)
 Cannabis 52 (13.5) 48 (11.0)
 Cocaine 49 (12.7) 70 (16.1)
 Stimulant 58 (15.0) 82 (18.9)
 Psychostimulant NOS 99 (25.7) 143 (32.9)
 PCP 2 (0.5) 1 (0.2)
 Benzodiazepine 15 (3.9) 15 (3.5)
 Nicotine 172 (44.6) 165 (37.9)
 Others 9 (2.3) 7 (1.6)
Psychiatric Historya
 Anxiety 144 (37.3) 170 (39.1)
 PTSD 70 (18.1) 75 (17.2)
 Depression 149 (38.6) 158 (36.3)
 Psychotic 9 (2.3) 9 (2.1)
 Bipolar Behavior 56 (14.5) 51 (11.7)
 Behavior, Conduct Disorderb 49 (12.7) 57 (13.1)
 Borderline Personality Disorder 7 (1.8) 8 (1.8)
 Other comorbidity 33 (8.6)c 18 (4.1)
a

Missing cases for drug use disorder (n = 1–13), psychiatric history (n = 8–13) were not shown at Table 1.

b

Including oppositional defiant, Intermittent explosive.

c

Differences in two groups at p < 0.01.